Keywords: اینترلوکین-۲; drug reaction; gp100; granuloma; granulomatous reaction; immunotherapy; interleukin-2; melanoma; melanoma-associated antigen 3; resiquimod; IL-2; interleukin-2 (); MAGE-3; melanoma-associated antigen 3 ();
مقالات ISI اینترلوکین-۲ (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین-۲; Autoimmune hepatitis; Cytokine; Interleukin-2; Interferon-gamma; Single nucleotide polymorphism;
Keywords: اینترلوکین-۲; Local delivery; Inflammation; Tumor necrosis factor alpha; Interleukin-2; Interferon gamma;
Keywords: اینترلوکین-۲; aHSC; activated hepatic stellate cells; rHSC; reverted hepatic stellate cells; qHSC; quiescent hepatic stellate cells; MSCs; mesenchymal stem cells; IL-1β; interleukin-1β; IL-2; interleukin-2; IL-6; interleukin-6; IL-8; interleukin-8; TGF-β; transformi
Keywords: اینترلوکین-۲; BACE; bronchial arterial chemoembolization; CBM; China biological medicine database; CNKI; China national knowledge infrastructure database; CENTRAL; Cochrane Central Register of Controlled Trials; Chi-CTR; Chinese clinical trial registry; DCR; disease co
Keywords: اینترلوکین-۲; 5-FU; 5-fluorouracil; AF; atrial fibrillation; ALK; anaplastic lymphoma kinase; APD; action potential duration; APL; acute promyelocytic leukemia; BCR-ABL; breakpoint cluster region-Abelson; BTK; Bruton tyrosine kinase; CD20; cluster of differentiation 20
Keywords: اینترلوکین-۲; 8-OHdG; 8-hydroxy-2â²-deoxyguanosine; AIC; Akaike Information Criterion; α-2-M; alpha-2-macroglobulin; Apo-AI; apolipoprotein A-I; Apo-AII; apolipoprotein A-II; CRP; C-reactive protein; CNF; carbon nanofibers; CNT; carbon nanotubes; CNT/F; carbon nanotu
Keywords: اینترلوکین-۲; AMD; age-related macular degeneration; ATP; adenosine triphosphate; A1R; adenosine receptor type A1; A2AR; adenosine receptor type A2A; A2BR; adenosine receptor type A2B; A3R; adenosine receptor type A3; BDNF; brain-derived neurotrophic factor; CI; contin
Keywords: اینترلوکین-۲; ANOVA; analysis of variance; APC; antigen presenting cell; AZPR; azathioprine; BA; Pbenzo(a)pyrene; CYA; cyclosporin A; CYPH; cyclophosphamide monohydrate; DEX; dexamethasone; DPBS; Dulbecco's phosphate-buffered saline; DMSO; dimethylsulfoxide; ELISA; enz
Keywords: اینترلوکین-۲; adjuvants; immunologic; carcinoma; renal cell; kidney neoplasms; ASSURE; Sunitinib Malate or Sorafenib Tosylate in Treating Patients with Kidney Cancer that was Removed by Surgery; CAIX; carbonic anhydrase IX; DFS; disease-free survival; ECOG; Eastern Coo
Keywords: اینترلوکین-۲; a7-nAChR; alpha7-nicotinic acetylcholine receptor; Ang II; angiotensin II; AP; area postrema; AR; adrenergic receptor; AT1R; angiotensin type 1 receptor; AT2R; angiotensin type 2 receptor; AV3V; anteroventral third ventricle; BBB; blood-brain barrier; CNS
Keywords: اینترلوکین-۲; Interleukin-2; Myocarditis; Cardiac magnetic resonance imaging; Renal cell carcinoma;
Keywords: اینترلوکین-۲; Psoriasis; Autoimmune disease; Metformin; Pioglitazone; CD4+ T cells; CD8+ T cells; Interleukin-2; C-reactive protein; Ceruloplasmin;
Keywords: اینترلوکین-۲; Morphometry; sarcopenia; interleukin-2; metastatic renal cell carcinoma; response prediction;
Keywords: اینترلوکین-۲; Parkinson's Disease; Multiple System Atrophy; Neuroinflammation; Interleukin-2; Interleukin-13; Granulocyte colony-stimulating factor; Major histocompatibility complex class II; CD45 reactivity; S100 calcium binding protein B; Glycogen synthase kinase 3 b
Keywords: اینترلوکین-۲; Immune checkpoint inhibitors; Interleukin-2; Lymphodepletion; Nonmyeloablative chemotherapy; Tumor-infiltrating lymphocytes;
Keywords: اینترلوکین-۲; DAC; 5-Aza-2â²-deoxycytydine; DNMT; DNA methyltransferase; HAT; histone acetyltransferase; HDAC; histone deacetylase; HDACì; HDAC inhibitors; IL-2; interleukin-2; INS; insulin; LADA; latent autoimmune diabetes in adults; miRNA; microRNA; PBMCs; peripher
Keywords: اینترلوکین-۲; ADF; acid detergent fiber; AIA; acid insoluble ash; BW; body weight; CF; crude fiber; CHs; Chinese herbs; CHC; Chinese herbal combination; CP; crude protein; DM; dry matter; EE; ether extract; GH; growth hormone; HSP70; heat shock 70Â kDa protein; IgA; im
Keywords: اینترلوکین-۲; Interleukin-2; Horse; Monoclonal antibody; Fluorescent bead assay; Flow cytometry;
Keywords: اینترلوکین-۲; kidney; carcinoma; renal cell; neoplasm metastasis; interleukin-2; molecular targeted therapy; CR; complete response; ECOG; Eastern Cooperative Oncology Group; HDIL-2; high dose IL-2; IL-2; interleukin-2; mRCC; metastatic RCC; OS; overall survival; PD; pr
Keywords: اینترلوکین-۲; In ovo feeding; l-Arginine; Inducible nitric oxide synthase; Mucosal immune function; DNA methylation; BW; body weight; CpG; cytosine-guanine nucleotide repeats; DG; diluent-injected control group; GALT; gut-associated lymphoid tissue; GIT; gastrointestin
Keywords: اینترلوکین-۲; Interleukin-2; Interferon-gamma; Single nucleotide polymorphism; Juvenile idiopathic arthritis; Children;
Keywords: اینترلوکین-۲; FKBP12, FK506 binding protein; IL-2, interleukin-2; PP2B, calcineurin phosphatase; PLGA, poly-d,l-lactic-co-glycolic acidBiodegradable microspheres; Calcineurin phosphatase; Interleukin-2; Rats and tacrolimus
Keywords: اینترلوکین-۲; ASK1; Apoptosis signal-regulating kinase 1; CNS; Central nervous system; DC; Dendritic cell; GATA3; GA-TA-binding protein-3; HIV; Human immunodeficiency virus; HL-60; Human promyelocytic leukemia cell line; IFN-γ; Interferon-γ; IL-1β; Interleukin-1β;
Keywords: اینترلوکین-۲; EGF; epidermal growth factor; FGF-2; fibroblast growth factor 2; GFAP; glial fibrillary acidic protein; hNPC; human neural progenitor cell; IL-2; interleukin-2; IL-4; interleukin-4; IL-6; interleukin-6; IL-8; interleukin-8; INL; inner nuclear layer; MCP-1
Keywords: اینترلوکین-۲; Active tuberculosis; Interferon-γ; Interleukin-2; Latent tuberculosis infection; QuantiFERON;
Keywords: اینترلوکین-۲; Memory-updating; Extinction; Immunosuppression; Cytokines; Interleukin-2;
Keywords: اینترلوکین-۲; Melanoma; Immunotherapy; History; Interleukin-2; Vaccine; CTLA-4; PD-1; Interferon;
Keywords: اینترلوکین-۲; VLS, vascular leak syndrome; RA, rheumatoid arthritis; TG, transgenicTumor necrosis factor-alpha; Vascular leak syndrome; Interleukin-2
Keywords: اینترلوکین-۲; Tumor cells; Effector cells; Interleukin-2; Delay;
Keywords: اینترلوکین-۲; Vascular targeting; Mantle cell lymphoma; Immunocytokine; Interleukin-2; Rituximab;
Keywords: اینترلوکین-۲; C/GP; chitosan/β-glycerophosphate; CMC; Carboxymethyl chitosan; DMSO; Dimethylsulfoxide; HA; hyaluronic acid; HEM; 2-hydroxyehthyl methacrylate; HPC; Hydroxypropylcellulose; HPMC; Hydroxypropylmethylcellulose; IL-2; interleukin-2; MA; maleic anhydride; M
Keywords: اینترلوکین-۲; ALDH; aldehyde dehydrogenase; BMC; bone marrow cells; CD4; cluster of differentiation 4; CD8; cluster of differentiation 8; CP; cyclophosphamide; CR3; complement receptor 3; CTL; cytotoxic T lymphocytes; DLC; differential leukocyte count; DNA; deoxyribonu
Keywords: اینترلوکین-۲; Radiation; Immunotherapy; Dose; Fractionation; MHC-I; major histocompatibility class I; ICAM-1; intercellular adhesion molecules-1; CEA; carcinoembryonic antigen; CTL; cytotoxic T cells; CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; gp 100; glycopr
Keywords: اینترلوکین-۲; Schizophrenia; Interleukin-2; Biological markers; Cognition; Behavioral symptoms;
Keywords: اینترلوکین-۲; Lymphocytes; Soluble IL-2 receptor alpha; Interleukin-2; Silica; Cytokines; Autoimmunity
Keywords: اینترلوکین-۲; ANOVA; analysis of variance; BDNF; brain-derived neurotrophic factor; EDTA; ethylenediaminetetraacetic acid; ELISA; enzyme-linked immunosorbent assay; GDNF; glia-derived-neurotrophic-factor; GFAP; glial fibrillary acidic protein; IL-2; interleukin-2; SD;
Keywords: اینترلوکین-۲; Th1; type 1 T helper cells; Th2; type 2 T helper cells; CNS; central nervous system; BBB; blood-brain barrier; IL-2; interleukin-2; IL-12; interleukin-12; IL-10; interleukin-10; IL-4; interleukin-4; IL-6; interleukin-6; TNF-α; tumor necrosis factor a
Keywords: اینترلوکین-۲; Melanoma; Cytokines; Interferon; Interleukin-2; Interleukin-21; Granulocyte-macrophage colony-stimulating factor;
Keywords: اینترلوکین-۲; AE; adverse effect; APC; antigen-presenting cells; CI; confidence interval; CP; carboplatin and paclitaxel; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4; cuSCC; cutaneous squamous cell carcinoma; FDA; Food and Drug Administ
Keywords: اینترلوکین-۲; 5-HT; 5-hydroxytryptophan; 5-HTTLPR; serotonin transporter linked polymorphic region; 8-iso; 8-iso-prostaglandin F2; 8-OHdG; 8-hydroxy-2â²-deoxyguanosine; ATP; adenosine triphosphate; BH4; 5,6,7,8-tetrahydrobiopterin; CMI; cell mediated immune; CRH; cort
Keywords: اینترلوکین-۲; BBB; blood-brain barrier; ECG; electrocardiogram; ETV; endoscopic third ventriculostomy; EVD; external ventricular drain; ICH; Intracerebral hemorrhage; ICP; intracranial pressure; IL-2; interleukin-2; IVH; intraventricular hemorrhage; PPAR; peroxisome
Keywords: اینترلوکین-۲; IgG; immunoglobulin G; IgM; immunoglobulin M; IgA; immunoglobulin A; sIgA; secretory immunoglobulin A; sCD4; soluble CD4; sCD8; soluble CD8; IL-1; interleukin-1; IL-2; interleukin-2; TNF-α; tumor necrosis factor-alpha; Cellular immunity; Chitosan; Humora
Keywords: اینترلوکین-۲; IL-6; interleukin-6; TNF-α; tumor necrosis factor- alpha; BMI; body mass index; MDD; major depressive disorder; MDD-M; major depressive disorder with melancholic features; MDD-A; major depressive disorder with atypical features; IL-1β; Interleukin-1be
Keywords: اینترلوکین-۲; EGF; epidermal growth factor; FGF-2; fibroblast growth factor-2; Flt3-L; Fms-related tyrosine kinase 3-ligand; GCSF; granulocyte colony stimulating factor; GMCSF; granulocyte monocyte colony stimulating factor; IFN-γ; interferon-γ; IL-1α; interleukin-1
Keywords: اینترلوکین-۲; CEO; chicken embryo origin; DIVA; differentiation of infected and vaccinated animals; ELISA; enzyme-linked immunosorbent assay; ELISPOT; enzyme-linked immunospot; gB; glycoprotein B; gG; glycoprotein G; IBDV; infectious bursal disease virus; IBV; infectio
Keywords: اینترلوکین-۲; AML; acute myeloid leukemia; CAM-DR; cell adhesion-mediated drug resistance; CCP; charge-conversion polymer; CLL; chronic lymphocytic leukemia; CNS; central nervous system; CSC; cancer stem cell; EGFR; epidermal growth factor receptor; EPR; enhanced perme
Keywords: اینترلوکین-۲; AICD; activation-induced cell death; AIDS; acquired immunodeficiency syndrome; APC; antigen presenting cells; CCF; cell-cell fusion; CNS; central nervous system compartment; DAE; differential-algebraic equations; ENV; Env-CD4 cross-linking mediated apop
Keywords: اینترلوکین-۲; Conditioned taste aversion; Cyclosporine A; Immunosuppression; Interleukin-2; Latent inhibition
Deficient mitochondrial biogenesis in IL-2 activated NK cells correlates with impaired PGC1-α upregulation in elderly humans
Keywords: اینترلوکین-۲; NK cells; Mitochondria; Interleukin-2; PGC-1α; Immunosenescence;